Invest in the Future of Non-Pharma Therapeutics.

We’re raising £3M as part of a blended round to scale our clinically validated, IP-protected deep tech platform — already trusted by 4,000+ weekly paying patients and responsible for over 380,000 insured sessions delivered to date.

Backed by Innovate UK (£150K grant) and the WMHTIA, we’re now expanding research in partnership with leading institutions and entering high-value markets including space health and GLP-1-associated muscle loss mitigation.

Why invest now?

  • High traction:
    Recurring weekly users, reimbursed by major insurers

  • Defensible tech:
    Patent applications filed, proprietary hardware + protocols

  • Clinical expansion in motion:
    Pilots underway at the PHTA and academic medical centres

  • Future-facing markets:
    Preparing for in-flight astronaut health and precision rehab

  • Strategic discussions:
    Already underway with leading insurers and pharmacy chains (e.g., Vitality, Boots, Walgreens)

Ready to Learn More?

Fill out the form to request an investor deck, Book a 1:1 call with our CEO or register interest before allocation fills.